Delivery Order SPE2DB20D1100-SPE2DB24FD4A2

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,259,183 units of the prescription medication alfuzosin hydrochloride extended-release 10 mg tablets. The contract, valued at $1,368.25, is a firm-fixed price delivery order awarded on July 26, 2024, with a completion date of July 29, 2024. This contract is not associated with a set-aside...
This contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is a $1,251.84 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4565114944 - Alfuzosin HCL ER 10 mg Tablets, 120 count, with a completion date of July 12, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with various federal agencies, including the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $4,677.91, is for the delivery of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,615.41 firm fixed-price delivery order is for the supply of Alfuzosin HCL ER 10 mg tablets. The contract has an ultimate completion date of September 12, 2024 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,644.03, is for the delivery of Alfuzosin HCL ER 10 mg tablets. This is a firm fixed price delivery order contract with an ultimate completion date of January 27, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,183.92 contract is for the supply of Alfuzosin Hydrochloride Extended Release (ER) 10 mg tablets. The order has a completion date of February 26, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,486.48 delivery order contract is for the supply of Alfuzosin HCL ER 10 mg tablets, and has a period of performance through October 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,193.49 delivery order contract is for the supply of Alfuzosin HCl ER 10 mg tablets. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) with an ultimate completion date of December 9, 2024. Amerisourcebergen holds a separate $999,999,999 IDC with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,728.40 fixed-price delivery order contract is for the supply of 90-count bottles of 10 mg Alfuzosin HCl extended-release tablets. The contract has a period of performance through March 26, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,018.77, is for the delivery of Alfuzosin HCL ER 10 mg tablets. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD4A2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,634.00 firm-fixed-price delivery order is for the supply of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets in 120-count packages. The contract has an ultimate completion date of August 23, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, for providing a wide range of pharmaceutical and medical products to support federal healthcare programs. This specific award is not designated as a set-aside contract.

Generated 11/21/24, 9:40 AM